Physician

Gilbert Kepecs, MD

According to 2025 Medicare claims, Gilbert Kepecs, MD (NPI: 1093710014) practices rheumatology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bergen, NJ. This provider's primary affiliated billing organization is HACKENSACK RHEUMATOLOGY LLC (NPI: 1184803173) and primary practice location at 07601-2570.

Kepecs' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 517 traditional Medicare patients, billed 138,531 HCPCS/CPT codes, and received $1,285,851 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,824 prescription claims across 509 beneficiaries totaling $3,198,307 in drug costs, led by Rinvoq (Upadacitinib). DME data shows 24 claims. Open Payments data shows 64 records totaling $1,181. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $1,467,788 to $3,198,307. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $2,979 to $17,493.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	623	86,918	$1,160,832
2016	603	99,318	$1,154,689
2017	588	72,118	$1,015,369
2018	626	74,034	$1,156,441
2019	557	108,959	$1,341,762
2020	540	110,293	$1,182,208
2021	542	88,823	$1,091,177
2022	529	93,930	$1,120,890
2023	515	107,786	$1,218,962
2024	517	138,531	$1,285,851

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	426	4,504	$1,467,788
2016	443	4,736	$1,668,770
2017	462	5,080	$2,104,168
2018	485	5,122	$2,328,795
2019	484	5,004	$2,611,315
2020	486	4,944	$2,460,072
2021	527	5,172	$2,679,299
2022	512	4,722	$2,953,634
2023	506	4,814	$3,111,893
2024	509	4,824	$3,198,307

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	23	$787
2023	N/R	22	$584
2024	N/R	24	$635

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	163	245	$112
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	416	972	$74
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	348	693	$14
96372	Injection of drug or substance under skin or into muscle	109	259	$13
36415	Insertion of needle into vein for collection of blood sample	240	571	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Rinvoq	Upadacitinib	64	2,216	$477,959
Humira(Cf) Pen	Adalimumab	51	1,568	$428,471
Enbrel Mini	Etanercept	52	1,456	$409,698
Xeljanz Xr	Tofacitinib Citrate	43	1,290	$246,323
Enbrel	Etanercept	30	840	$216,643

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	12	$409
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	12	$226

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	64	$1,181	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Gilbert Kepecs, MD?

Tedicare shows public-source Medicare data for Gilbert Kepecs, MD (NPI 1093710014), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gilbert Kepecs, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Gilbert Kepecs, MD?

Gilbert Kepecs, MD is linked to HACKENSACK RHEUMATOLOGY LLC (billing NPI 1184803173) in the available physician profile data.

Does Gilbert Kepecs, MD have Open Payments data?

Gilbert Kepecs, MD has 64 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.